Phoenix Life Sciences International Ltd, formerly MediJane Holdings, Inc., is a global healthcare solutions company. The Company is focused on advancing research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. Its pharmaceutical products contains extracts from medical cannabis, which includes medical cannabis products for doctors prescription, as well as products for the targeted treatment of specific conditions, such as diabetes and cervical cancer. Its products include Phoenix Daily, Phoenix Relax, Phoenix Sleep, Phoenix Sport Plus, Phoenix Metabolic, Phoenix Onco, Phoenix Pain, Phoenix Mood and Phoenix Neuro. Its provides its products through various forms, including soft gel, oral thin film (OTF), sublingual tablets, transdermal patches, suppository and tropical cream.
No insider trading activity.
Information provided by , Copyright © 2019. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.